Bavarian Nordic (BAVA)

Copenhagen
Currency in DKK
170.4
+0.1(+0.06%)
Real-time Data
BAVA Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Fair Value
Day's Range
169.5173.1
52 wk Range
143.4300.0
Key Statistics
Edit
Prev. Close
170.3
Open
171.6
Day's Range
169.5-173.1
52 wk Range
143.4-300
Volume
53.8K
Average Volume (3m)
395.83K
1-Year Change
9.8%
Book Value / Share
136.04
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
BAVA Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Price Target
306.0
Upside
+79.58%
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a low P/E ratio relative to near-term earnings growth
Show more

Bavarian Nordic Company Profile

Bavarian Nordic A/S develops, manufactures, and commercializes life-saving vaccines. The company offers non-replicating smallpox and monkeypox vaccines under the IMVAMUNE, IMVANEX, and JYNNEOS names; rabies vaccine for human use under the Rabipur/RabAvert name; tick-borne encephalitis vaccine under the Encepur name; and Ebola vaccine under the MVABEA name. It is also developing MVA-BN for the treatment of smallpox. It operates in the United States, Canada, France, Germany, Spain, Australia, Switzerland, Sweden, Chile, Taiwan, the United Kingdom, Hong Kong, Saudi Arabia, Belgium, and internationally. Bavarian Nordic A/S was incorporated in 1992 and is headquartered in Hellerup, Denmark.

Employees
1609
Market
Denmark

Compare BAVA to Peers and Sector

Metrics to compare
BAVA
Peers
Sector
Relationship
P/E Ratio
11.8x−5.1x−0.6x
PEG Ratio
0.24−0.230.00
Price/Book
1.2x2.7x2.6x
Price / LTM Sales
2.2x20.3x3.1x
Upside (Analyst Target)
63.8%85.2%51.8%
Fair Value Upside
Unlock11.5%8.3%Unlock

Analyst Ratings

3 Buy
0 Hold
0 Sell
Ratings:
3 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 306.0
(+79.58% Upside)

Earnings

Latest Release
Nov 14, 2024
EPS / Forecast
0.90 / 4.70
Revenue / Forecast
1.36B / 1.68B
EPS Revisions
Last 90 days

People Also Watch

579.7
NOVOb
-1.02%
1,436.5
GMAB
+4.62%
11.750
RGTI
+6.62%
1,435.5
DSV
0.00%
8.2600
QUBT
+4.96%

FAQ

What Is the Bavarian Nordic (BAVA) Stock Price Today?

The Bavarian Nordic stock price today is 170.40

What Stock Exchange Does Bavarian Nordic Trade On?

Bavarian Nordic is listed and trades on the Copenhagen stock exchange.

What Is the Stock Symbol for Bavarian Nordic?

The stock symbol for Bavarian Nordic is "BAVA."

What Is the Bavarian Nordic Market Cap?

As of today, Bavarian Nordic market cap is 13.26B.

What is Bavarian Nordic Earnings Per Share?

The Bavarian Nordic EPS is 14.26.

What Is the Next Bavarian Nordic Earnings Date?

Bavarian Nordic will release its next earnings report on Mar 04, 2025.

From a Technical Analysis Perspective, Is BAVA a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.